Welgene Biotech Co.,Ltd.
6661
Rank in Stocks
#28202
Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis... Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis services. The company provides comprehensive support for scientific research, employing a range of advanced laboratory techniques such as genetic sequencing, microarray analysis, qPCR verification, nucleic acid extraction and quality control, LCM single cell experimentation, and intricate bioinformatics analysis. A key offering in their portfolio is Cytoscan, an array-based comparative genomic hybridization (CGH) solution. Beyond services, Welgene Biotech also supplies essential laboratory products, including various reagents, consumable items, and specialized instruments, alongside dedicated software solutions. Established in 2003, the company operates from its headquarters in Taipei City, Taiwan.
Share Price
$0.48665356
Last synced: 2026-11-12
Market Cap
$11.84M
Change (1 day)
0.29%
Change (1 year)
-19.19%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Welgene Biotech Co.,Ltd. (6661)
Category
Healthcare
EPS for Welgene Biotech Co.,Ltd. (6661)
EPS as of June 2026 TTM: $0.00
According to Welgene Biotech Co.,Ltd.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for Welgene Biotech Co.,Ltd. from 2014 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 20.00% |
| 2025 | 0.00 | 20.00% |
| 2024 | 0.00 | -141.67% |
| 2023 | 0.00 | -126.87% |
| 2022 | $0.01 | -37.09% |
| 2021 | $0.02 | -58.48% |
| 2020 | $0.05 | 3.01% |
| 2019 | $0.05 | 11.16% |
| 2018 | $0.04 | 16.67% |
| 2017 | $0.04 | 519.35% |
| 2016 | $0.01 | -84.65% |
| 2015 | $0.04 | -33.66% |
| 2014 | $0.06 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | -904,385.71% |
US
|
|
| $6.12 | -291,528.57% |
US
|
|
| $1.38 | -65,676.19% |
CN
|
|
| $14.83 | -706,290.48% |
US
|
|
| $5.09 | -242,480.95% |
US
|
Questions about Welgene Biotech Co.,Ltd.'s earnings per share (EPS)
What is Welgene Biotech Co.,Ltd.'s earnings per share (EPS)?
Welgene Biotech Co.,Ltd.'s earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2026.
What was Welgene Biotech Co.,Ltd.'s earnings per share (EPS) in 2025?
In 2025, Welgene Biotech Co.,Ltd.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has Welgene Biotech Co.,Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Welgene Biotech Co.,Ltd.'s earnings per share (EPS) was highest in 2020 ($0.05) and lowest in 2025 (0.00).
How does Welgene Biotech Co.,Ltd.'s earnings per share (EPS) compare with similar companies?
Welgene Biotech Co.,Ltd.'s earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.